TransMedics (TMDX) Gross Profit (2018 - 2026)

TransMedics' Gross Profit history runs 9 years deep, the most recent figure standing at $101.2 million for Q1 2026.

• In Q1 2026, Gross Profit rose 14.66% year-over-year to $101.2 million; the TTM figure through Mar 2026 stood at $375.7 million (up 29.41% YoY), while the FY2025 annual figure was $362.8 million, up 38.43% from the prior year.
• Gross Profit was $101.2 million for Q1 2026 at TransMedics, up from $93.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $101.2 million in Q1 2026 to a low of $12.1 million in Q1 2022.
• Historically, Gross Profit has averaged $55.6 million across 5 years, with a median of $60.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Gross Profit surged 380.12% in 2022, then climbed 14.66% in 2026.
• A 5-year view of Gross Profit shows it stood at $20.7 million in 2022, then soared by 131.48% to $47.9 million in 2023, then soared by 50.27% to $72.0 million in 2024, then advanced by 29.72% to $93.4 million in 2025, then grew by 8.29% to $101.2 million in 2026.
• The last three Gross Profit figures came in at $101.2 million (Q1 2026), $93.4 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.